JULIA WRONA: Open Payments
NPI 1346881927 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 47 payments from 14 companies in 2025. Trend: 2023 $2,520 · 2024 $2,857 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 6 | $249 |
| United Therapeutics Corporation | 8 | $185 |
| Actelion Pharmaceuticals US, Inc. | 7 | $180 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $161 |
| Novartis Pharmaceuticals Corporation | 6 | $120 |
| Merck Sharp & Dohme LLC | 3 | $84 |
| Novo Nordisk Inc | 3 | $76 |
| BridgeBio Pharma, Inc. | 2 | $63 |
| SCPHARMACEUTICALS INC. | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $46 |
Products named: Tyvaso, Kerendia, UPTRAVI, PASCAL, LEQVIO, SAPIEN 3 Ultra RESILIA, Wegovy, VERQUVO.
Industry payments across NV — which companies pay providers there.
